Effect of botulinum toxin injection for achalasia in Thai patients

Journal of the Medical Association of Thailand

Volumn 89, Issue SUPPL. 5, 2006, Pages

  Leelakusolvong, Somchai ^a   Sinpeng, Tawesub ^a   Pongprasobchai, Supot ^a   Tanwandee, Tawesak ^a   Kachintorn, Udom ^a   Manatsathit, Sathaporn ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Achalasia; Botox; Botulinum toxin; Thais

Indexed keywords

BOTULINUM TOXIN;

ADULT; AGED; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; ESOPHAGUS ACHALASIA; FEMALE; FOLLOW UP; HEARTBURN; HUMAN; LONG TERM CARE; LOW DRUG DOSE; LOWER ESOPHAGUS SPHINCTER; MALE; OUTCOME ASSESSMENT; RECOMMENDED DRUG DOSE; RECURRENT DISEASE; REFLUX ESOPHAGITIS; SCORING SYSTEM; SIDE EFFECT; THAILAND; THORAX PAIN; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; ENDOSCOPY, DIGESTIVE SYSTEM; ESOPHAGEAL ACHALASIA; ESOPHAGUS; FEMALE; HUMANS; MALE; MANOMETRY; MIDDLE AGED; RETROSPECTIVE STUDIES; THAILAND; TREATMENT OUTCOME;

EID: 33846659719     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Traube M. On drugs and dilators for achalasia. Dig Dis Sci 1991; 36: 257-9.
2. Heitmann P, Espinoza J, Csendes A. Physiology of the distal esophagus in achalasia. Scand J Gastroenterol 1969; 4: 1-11.
3. Holloway RH, Dodds WJ, Helm JF, Hogan WJ, Dent J, Arndorfer RC. Integrity of cholinergic innervation to the lower esophageal sphincter in achalasia. Gastroenterology 1986; 90: 924-9.
4. Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN. Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med 1995; 332: 774-8.
5. Eckardt VF, Aignherr C, Bernhard G. Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology 1992; 103: 1732-8.
6. Annese V, Bassotti G, Coccia G, Dinelli M, D'Onofrio V, Gatto G, et al. A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group. Gut 2000; 46: 597-600.
7. Pasricha PJ, Rai R, Ravich WJ, Hendrix TR, Kalloo AN. Botulinum toxin for achalasia: long-term outcome and predictors of response. Gastroenterology 1996; 110: 1410-5.
8. Pasricha PJ, Ravich WJ, Kalloo AN. Botulinum toxin for achalasia. Lancet 1993; 341: 244-5.
9. Sharp KW, Khaitan L, Scholz S, Holzman MD, Richards WO. 100 consecutive minimally invasive Heller myotomies: lessons learned. Ann Surg 2002; 235: 631-8.
10. Gui D, Rossi S, Runfola M, Magalini SC. Review article: botulinum toxin in the therapy of gastrointestinal motility disorders. Aliment Pharmacol Ther 2003; 18: 1-16.
11. Wehrmann T, Kokabpick H, Jacobi V, Seifert H, Lembcke B, Caspary WF. Long-term results of endoscopic injection of botulinum toxin in elderly achalasic patients with tortuous megaesophagus or epiphrenic diverticulum. Endoscopy 1999; 31: 352-8.
12. Zhao X, Pasricha PJ. Botulinum toxin for spastic GI disorders: a systematic review. Gastrointest Endosc 2003; 57: 219-35.